Evidence map›Paper›PMID 33435608›Full record

ArticlePolymers2021

Protective Face Mask Filter Capable of Inactivating SARS-CoV-2, and Methicillin-Resistant

Miguel Martí, Alberto Tuñón-Molina, Finn Lillelund Aachmann, Yukiko Muramoto, Takeshi Noda, Kazuo Takayama, Ángel Serrano-Aroca

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. A Novel Antipathogenic Agent for Nonwoven Fabric.Biomedical materials & devices (New York, N.Y.) · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Modification of face masks with zeolite imidazolate framework-8: A tool for hindering the spread of COVID-19 infection.Microporous and mesoporous materials : the official journal of the International Zeolite Association · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Miguel MartíBiomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia San Vicente Mártir, c/Guillem de Castro 94, 46001 Valencia, Spain.ORCID 0000-0002-1891-8368
Alberto Tuñón-MolinaBiomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia San Vicente Mártir, c/Guillem de Castro 94, 46001 Valencia, Spain.ORCID 0000-0003-3819-7390
Finn Lillelund AachmannThe Norwegian Biopolymer Laboratory (NOBIPOL), Department of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Sem Sælands vei6-8, N-7491 Trondheim, Norway.ORCID 0000-0003-1613-4663
Yukiko MuramotoLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Takeshi NodaLaboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Kazuo TakayamaCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8397, Japan.ORCID 0000-0002-1132-2457
Ángel Serrano-ArocaBiomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia San Vicente Mártir, c/Guillem de Castro 94, 46001 Valencia, Spain.ORCID 0000-0002-9953-3848
Kyoto University · JPValencia Catholic University Saint Vincent Martyr · ESNorwegian University of Science and Technology · NO

Funding

FUNDACIÓN UNIVERSIDAD CATÓLICA DE VALENCIA 2020-231-001UCVJapan Agency for Medical Research and Development (AMED) 20fk0108270h0001, 20fk0108263s0201
6 · The paper itself

Abstract

Face masks have globally been accepted to be an effective protective tool to prevent bacterial and viral transmission, especially against indoor aerosol transmission. However, commercial face masks contain filters that are made of materials that are not capable of inactivating either SARS-CoV-2 or multidrug-resistant bacteria. Therefore, symptomatic and asymptomatic individuals can infect other people even if they wear them because some viable viral or bacterial loads can escape from the masks. Furthermore, viral or bacterial contact transmission can occur after touching the mask, which constitutes an increasing source of contaminated biological waste. Additionally, bacterial pathogens contribute to the SARS-CoV-2-mediated pneumonia disease complex, and their resistance to antibiotics in pneumonia treatment is increasing at an alarming rate. In this regard, herein, we report the development of a non-woven face mask filter fabricated with a biofunctional coating of benzalkonium chloride that is capable of inactivating more than 99% of SARS-CoV-2 particles in one minute of contact, and the life-threatening methicillin-resistant

Indexed as

benzalkonium chlorideCOVID-19face mask filterMRSAMRSEmultidrug-resistant bacteriaSARS-CoV-2

Identifiers

PMID33435608
PMCPMC7827663
OpenAlexW3119001899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.